The Emerging Roles of Hydrogen Sulfide in Ferroptosis
Antioxidants & Redox Signaling · 01.12.2024 · 41 (16-18) · 1150-1172
DOI: 10.1089/ars.2023.0535 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, erschienen am 01.12.2024. Verfasst von Yi-Wen Zhu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, School of Stomatology, Henan University, Kaife…. Hauptthemen laut MEDLINE: Hydrogen Sulfide, Ferroptosis, Signal Transduction. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 245 Literaturangaben.
Abstract (Originalsprache)
Significance: Ferroptosis, a form of regulated cell death characterized by a large amount of lipid peroxidation-mediated membrane damage, joins the evolution of multisystem diseases, for instance, neurodegenerative diseases, chronic obstructive pulmonary disease, acute respiratory distress syndrome, osteoporosis, osteoarthritis, and so forth. Since being identified as the third gasotransmitter in living organisms, the intricate role of hydrogen sulfide (H2S) in ferroptosis has emerged at the forefront of research. Recent Advances: Novel targets in the relevant metabolic pathways have been found, including transferrin receptor 1, cystine/glutamate antiporter, and others, coupled with the exploration of new signaling pathways, particularly the p53 signaling pathway, the nitric oxide/nuclear factor erythroid 2-related factor 2 signaling pathway, and so on. Many diseases such as emphysema and airway inflammation, myocardial diseases, endothelial dysfunction in aging arteries, and traumatic brain injury have recently been found to be alleviated directly by H2S inhibition of ferroptosis. Safe, effective, and tolerable novel H2S donors have been developed and have shown promising results in phase I clinical trials. Critical Issues: Complicated cross talk between the ferroptosis signaling pathway and oncogenic factors results in the risk of cancer when inhibiting ferroptosis. Notably, targeted delivery of H2S is still a challenging task. Future Directions: Discovering more reliable and stable novel H2S donors and achieving their targeted delivery will enable further clinical trials for diseases associated with ferroptosis inhibition by H2S, determining their safety, efficacy, and tolerance. Antioxid. Redox Signal. 41, 1150-1172.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, School of Stomatology, Henan University, Kaifeng, China.
- The First Affiliated Hospital of Henan University, Kaifeng, China.
- Kaifeng Key Laboratory of Infection and Biological Safety, School of Basic Medical Sciences, Henan University, Kaifeng, China.
- Department of Stomatology, Huaihe Hospital of Henan University, School of Stomatology, Henan University, Kaifeng, China.
ORCID-Profile: Xiao-Yi Liang, Yan Wang, Dong-Dong Wu
Zitieren
APA
Zhu, Y. W., Liu, Z. T., Tang, A. Q., Liang, X. Y., Wang, Y., Liu, Y. F., Jin, Y. Q., Gao, W., Yuan, H., Wang, D. Y., Ji, X. Y., & Wu, D. D. (2024). The Emerging Roles of Hydrogen Sulfide in Ferroptosis. Antioxidants & Redox Signaling, 41(16-18), 1150-1172. https://doi.org/10.1089/ars.2023.0535
Vancouver
Zhu YW, Liu ZT, Tang AQ, Liang XY, Wang Y, Liu YF, et al. The Emerging Roles of Hydrogen Sulfide in Ferroptosis. Antioxidants & Redox Signaling. 2024;41(16-18):1150-1172. doi:10.1089/ars.2023.0535
BibTeX
@article{Zhu2024,
author = {Zhu, Yi-Wen and Liu, Zi-Tao and Tang, Ao-Qi and Liang, Xiao-Yi and Wang, Yan and Liu, Ya-Fang and Jin, Yu-Qing and Gao, Wei and Yuan, Hang and Wang, Da-Yong and Ji, Xin-Ying and Wu, Dong-Dong},
title = {The Emerging Roles of Hydrogen Sulfide in Ferroptosis},
journal = {Antioxidants & Redox Signaling},
year = {2024},
volume = {41},
number = {16-18},
pages = {1150--1172},
doi = {10.1089/ars.2023.0535}
}
EUVIMED